Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2006
05/03/2006CN1254535C Nano superoxide dismutase and preparation method
05/03/2006CN1254484C Solid-phase synthesis process of octreotide acetate
05/03/2006CN1254473C Process for crystallization of(R)-or(S)-lansoprazole
05/03/2006CN1254273C Pharmaceutically stable hemostatic compositions
05/03/2006CN1254269C 'Bingshe' antalgesic plaster
05/03/2006CN1254267C Medicine for treating gastral cavity pain and its preparation method
05/03/2006CN1254262C Compound cold-treating tablet and its manufacturing method
05/03/2006CN1254259C Chinese medicinal preparations for cardiac and encephalic blood vessel diseases and productions thereof
05/03/2006CN1254258C Method for treating bacterial infection-type dermatopath and its preparing process
05/03/2006CN1254257C Chinese medicinal bag for nourishing face and supplementing qi
05/03/2006CN1254256C Compound dantong tablet (film coating tablet for disorder of gallbladder) and its manufacturing method
05/03/2006CN1254246C Silaenafil and oral disintegration tablet of its pharmaceutically receptible salt and its preparing method
05/03/2006CN1254245C Hydroxy camptothecin emulsion and its preparation method
05/03/2006CN1254244C Balofoxacin liquid preparation ,preparing method and its use
05/03/2006CN1254243C Pharmaceutical compositions comprising chelidonine or derivatives thereof
05/03/2006CN1254240C Silibinin meglumine salt oral disintegration tablet and its preparing method
05/03/2006CN1254237C Clear aqueous anaesthetic composition
05/03/2006CN1254236C Lyophilized preparation of civeleth sodium
05/03/2006CN1254235C Manufacturing technique of fine Fanhuncao granula formulation
05/03/2006CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex
05/03/2006CN1254233C Aqueous dispersion comprising stable nanoparticles of a water-insoluble and an excipient like middle chain triglycerides (MCT)
05/03/2006CN1254186C Tea taste chewing gum without sugar and its preparation
05/02/2006US7038085 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
05/02/2006US7038029 Vaccination
05/02/2006US7037943 comprising placing a stimulating substance in the eye between the internal limiting membrane and the retina; free of artificial structures, such as tacks or adhesives; for treatment of retinitis pigmentosa, macular degeneration, and retinal bleeding or traction; biocompatability
05/02/2006US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
05/02/2006US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors
05/02/2006US7037570 Pre-formed objects
05/02/2006US7037533 Functional agent for decomposing nicotine and method of preparing the same
05/02/2006US7037530 Mixture containing silica; blending, granulation
05/02/2006US7037529 Spraying a suspension of microionized fenofibrate and polyvinylpyrrolidone onto an inert hydrosoluble carrier; immediate-release; improved dissolution
05/02/2006US7037528 Microprecipitation method for preparing submicron suspensions
05/02/2006US7037526 Film preparation for biphasic release of pharmacologically active or other substances
05/02/2006US7037525 Oxacarbazepine film-coated tablets
05/02/2006US7037524 Oral delivery of a botanical
05/02/2006US7037523 Controlled release compositions for macrolide antimicrobial agents
05/02/2006US7037522 Nocturnal muscle enhancing composition and method
05/02/2006US7037521 extracting low molecular weight components from hydrophobic polydimethylsiloxane capsules with opening, laser cutting, shaping, filling with drugs, then covering with hydrophilic polyvinyl alcohol
05/02/2006US7037520 Reversible masking of liposomal complexes for targeted delivery
05/02/2006US7037519 Nutritional supplement and methods of making
05/02/2006US7037517 biochemical immobilization; for coating contact lenses, intraocular lense; improved hydrophilic-lipophilic balance; drug delivery; biodegradability; bioavailability
05/02/2006US7037516 comprises nonionic surfactants such as polyoxyethylene-stearate for sustaining elevated milk production response in lactating mammals; improved bioavailability
05/02/2006US7037514 agar gel sheets, formed by subjecting raw seaweed to extraction in neutral hot water, with no supporting layers having high adhesion force to skin, transparent appearance, and moistening/cooling effects
05/02/2006US7037513 Bodywash additives
05/02/2006US7037512 Skin and hair sunblocks; smooth, uniform, lustrous, visually appealing, healthy look
05/02/2006US7037511 water-in-oil emulsion containing fatty and/or wax components, water phase, hydrophilic/lipophilic (amphiphilic at interface) pigment particles, and emulsifier
05/02/2006US7037500 Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity
05/02/2006US7037499 Adjuvant for transcutaneous immunization
05/02/2006US7037450 Production scale method of forming microparticles
05/02/2006US7037439 Ultrafine particles homogeneously distributed in a mixture of vegetable oil and waxy solid
05/02/2006US7037304 Implantable system for cell growth control
05/02/2006CA2490601C Method for preparing solid dosage form of desmopressin
05/02/2006CA2192110C Active substance carrier for the controlled release of active substances in the gastrointestinal tract with delayed passage through the pylorus
05/02/2006CA2046448C Dosage form for administering a drug to effect circadian therapy
04/2006
04/27/2006WO2006045006A1 Antibiotic product formulation
04/27/2006WO2006044805A2 Less abusable pharmaceutical preparations
04/27/2006WO2006044785A1 Process for making antimicrobial polymer articles
04/27/2006WO2006044660A2 Functionalized solid lipid nanoparticles and methods of making and using same
04/27/2006WO2006044595A2 Effervescent pressed gum tablet compositions
04/27/2006WO2006044421A2 Cardiac safe, rapid medication delivery
04/27/2006WO2006044334A2 Platelet-derived growth factor compositions and methods of use thereof
04/27/2006WO2006044206A2 Transdermal drug delivery device including an occlusive backing
04/27/2006WO2006044202A2 Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
04/27/2006WO2006044086A1 Pool chemical tablet
04/27/2006WO2006044077A2 Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
04/27/2006WO2006044049A2 Method of providing customized drug delivery systems
04/27/2006WO2006043965A1 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
04/27/2006WO2006043830A1 Food supplement containing fish oil
04/27/2006WO2006043705A1 Type ii cubic liquid crystal composition
04/27/2006WO2006043521A1 Optically active oligonucleic acid compound containing phosphorothioate bond
04/27/2006WO2006043443A1 Process for producing microsphere with use of metal substrate having through-hole
04/27/2006WO2006043172A1 Pharmaceutical compositions and methods for sub-tenon delivery
04/27/2006WO2006043083A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
04/27/2006WO2006043025A1 Granular compositions comprising solidified melt granules of a cox-2 selective inhibitor
04/27/2006WO2006042744A1 Animal feedstuff dyeing and animal drugs
04/27/2006WO2006042701A1 Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
04/27/2006WO2006042662A1 Parenteral forms of administration of imexon and method for the production thereof
04/27/2006WO2006042429A1 Self-sealing antiseptic plaster
04/27/2006WO2006027786A3 Use of liposomal glucocorticoids for treating inflammatory states
04/27/2006WO2006014788A8 Methods of use of herbal compositions
04/27/2006WO2006008757A3 Stabilized pharmaceutical compositions of pravastatin
04/27/2006WO2006007354A3 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
04/27/2006WO2006005507A3 Pharmaceutical composition of piperazine derivatives
04/27/2006WO2005123134A3 A controlled release delivery system for metformin
04/27/2006WO2005120173A3 Anti-microbial activity of biologically stabilized silver nano particles
04/27/2006WO2005117829A3 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
04/27/2006WO2005107720A3 Sealed capsule including and integrated puncturing mechanism
04/27/2006WO2005105067A3 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
04/27/2006WO2005101983A3 Gastric retention system
04/27/2006WO2005099676A3 Transdermal delivery system for use with basic permeation enhancers
04/27/2006WO2005079757A3 Therapeutic agent carrier compositions
04/27/2006WO2005065650A3 Aerosol formulations comprising a carboxylic acid surfactant
04/27/2006WO2005065641A3 Non-disintegrating oral solid composition of high dose of water soluble drugs
04/27/2006WO2005065383A3 Oxidative reductive potential water solution, processes for producing same and methods of using the same
04/27/2006WO2005063205A3 Injectable phosphatidylcholine preparations
04/27/2006WO2005053689A3 Pharmaceutical compositions comprising lercanidipine
04/27/2006WO2005051348A3 Enteric-coated tablets of pantoprazole
04/27/2006WO2005048979A3 Pharmaceutical composition having casing with multiple micro tablets
04/27/2006WO2005040349A3 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site
04/27/2006WO2005027884A3 Stabilized ocular solutions